Authors:
MANDAK JS
BLANKENSHIP JC
GARDNER LH
BERKOWITZ SD
AGUIRRE FV
SIGMON KN
TIMMIS GC
GILCHRIST IC
MCIVOR M
RESAR J
WEINER BH
GEORGE BS
TALLEY JD
LINCOFF AM
TCHENG JE
CALIFF RM
TOPOL EJ
Citation: Js. Mandak et al., MODIFIABLE RISK-FACTORS FOR VASCULAR ACCESS SITE COMPLICATIONS IN THEIMPACT-II TRIAL OF ANGIOPLASTY WITH VERSUS WITHOUT EPTIFIBATIDE, Journal of the American College of Cardiology, 31(7), 1998, pp. 1518-1524
Citation: Jc. Blankenship et Ac. Ford, THERAPEUTIC REPOSITIONING OF A GIANTURCO-ROUBIN-II CORONARY STENT AFTER INITIAL DEPLOYMENT, Catheterization and cardiovascular diagnosis, 45(1), 1998, pp. 57-60
Authors:
CHU KH
MENAPACE FJ
BLANKENSHIP JC
HAUSCH R
HARRINGTON T
Citation: Kh. Chu et al., POLYARTERITIS-NODOSA PRESENTING AS ACUTE MYOCARDIAL-INFARCTION WITH CORONARY DISSECTION, Catheterization and cardiovascular diagnosis, 44(3), 1998, pp. 320-324
Authors:
BHAGWANDIEN NS
SHAH N
COSTELLO JM
GILBERT CL
BLANKENSHIP JC
Citation: Ns. Bhagwandien et al., ECHOCARDIOGRAPHIC DETECTION OF PULMONARY VALVE PAPILLARY FIBROELASTOMA, Journal of Cardiovascular Surgery, 39(3), 1998, pp. 351-354
Authors:
BLANKENSHIP JC
GODFREY NK
BALOG G
DEMKO SL
TCHENG JE
Citation: Jc. Blankenship et al., HOW DID ACIXIMAB DECREASE ISCHEMIC COMPLICATIONS DURING CORONARY INTERVENTION IN EPISTENT - ANALYSIS OF IN-LAB ADVERSE EVENTS, Circulation, 98(17), 1998, pp. 3018-3018
Authors:
BLANKENSHIP JC
HELLKAMP AS
AGUIRRE FV
DEMKO SL
TOPOL EJ
CALIFF RM
Citation: Jc. Blankenship et al., VASCULAR ACCESS SITE COMPLICATIONS AFTER PERCUTANEOUS CORONARY INTERVENTION WITH ABCIXIMAB IN THE EVALUATION OF C7E3 FOR THE PREVENTION OF ISCHEMIC COMPLICATIONS (EPIC) TRIAL, The American journal of cardiology, 81(1), 1998, pp. 36-40
Authors:
BLANKENSHIP JC
HELLKAMP AS
DEMKO SL
AGUIRRE FV
TOPOL EJ
CALIFF RM
Citation: Jc. Blankenship et al., VASCULAR ACCESS SITE COMPLICATIONS AFTER PERCUTANEOUS CORONARY INTERVENTION WITH GLYCOPROTEIN IIB IIIA RECEPTOR INHIBITOR THERAPY IN THE EPIC TRIAL/, Journal of the American College of Cardiology, 29(2), 1997, pp. 99310-99310
Authors:
BLANKENSHIP JC
ANDERSON KM
DEMKO L
CABOT CF
KEREIAKES DJ
AGUIRRE FV
Citation: Jc. Blankenship et al., DECREASED VASCULAR ACCESS SITE BLEEDING AFTER CORONARY INTERVENTION WITH ABCIXIMAB IN THE EPILOG VS THE EPIC TRIAL, Circulation, 96(8), 1997, pp. 896-896
Authors:
BLANKENSHIP JC
ANDERSON KM
DEMKO SL
LINCOFF AM
TCHENG JE
CABOT CF
Citation: Jc. Blankenship et al., IN-LAB ANGIOGRAPHIC COMPLICATIONS DURING CORONARY INTERVENTION WITH ABCIXIMAB VS PLACEBO IN THE EPILOG TRIAL, Circulation, 96(8), 1997, pp. 905-905
Citation: Jc. Blankenship et al., TELEPHONE REPORTING OF CARDIAC PROCEDURE RESULTS TO PRIMARY-CARE PHYSICIANS, The American journal of cardiology, 79(7), 1997, pp. 984
Authors:
LEFKOVITS J
BLANKENSHIP JC
ANDERSON KM
STONER GL
TALLEY JD
WORLEY SJ
WEISMAN HF
CALIFF RM
TOPOL EJ
Citation: J. Lefkovits et al., INCREASED RISK OF NON-Q-WAVE MYOCARDIAL-INFARCTION AFTER DIRECTIONAL ATHERECTOMY IS PLATELET DEPENDENT - EVIDENCE FROM THE EPIC TRIAL, Journal of the American College of Cardiology, 28(4), 1996, pp. 849-855
Authors:
AGUIRRE FV
TOPOL EJ
FERGUSON JJ
BLANKENSHIP JC
GARDNER LH
CARACCIOLO EA
DONOHUE TJ
HARRINGTON RA
TCHENG JE
Citation: Fv. Aguirre et al., EFFECT OF PLATELET GLYCOPROTEIN (GP) IIB IIIA ANTAGONISM WITH INTEGRILIN ON ACTIVATED CLOTTING TIMES DURING CORONARY INTERVENTIONS - RESULTS FROM THE IMPACT-II TRIAL/, Circulation, 94(8), 1996, pp. 1148-1148
Authors:
BLANKENSHIP JC
SIGMON KN
TARDIFF BE
DEMKO SL
TCHENG JE
Citation: Jc. Blankenship et al., EFFECT OF GLYCOPROTEIN IIB IIIA RECEPTOR INHIBITION ON SPECIFIC IN-LAB COMPLICATIONS OF CORONARY INTERVENTION AND RESULTANT CKMB ELEVATION IN THE IMPACT-II TRIAL/, Circulation, 94(8), 1996, pp. 1150-1150
Citation: Jc. Blankenship, RIGHT CORONARY-ARTERY PSEUDO-TRANSECTION DUE TO MECHANICAL STRAIGHTENING DURING CORONARY ANGIOPLASTY, Catheterization and cardiovascular diagnosis, 36(1), 1995, pp. 43-45
Citation: Jc. Blankenship et al., TRANSLUMINAL EXTRACTION CATHETER ATHERECTOMY IN LONG SAPHENOUS-VEIN GRAFTS, Catheterization and cardiovascular diagnosis, 35(4), 1995, pp. 368-372
Citation: Jc. Blankenship et al., CORONARY DISSECTION RESULTING FROM ANGIOPLASTY WITH SLOW OSCILLATING VS RAPID INFLATION AND SLOW VS RAPID DEFLATION, Catheterization and cardiovascular diagnosis, 34(3), 1995, pp. 202-209
Citation: Jc. Blankenship et al., PROSPECTIVE ASSESSMENT OF CHOLESTEROL EMBOLIZATION IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION TREATED WITH THROMBOLYTIC VS CONSERVATIVE THERAPY, Chest, 107(3), 1995, pp. 662-668
Authors:
AGUIRRE FV
TOPOL EJ
FERGUSON JJ
ANDERSON K
BLANKENSHIP JC
HEUSER RR
SIGMON K
TAYLOR M
GOTTLIEB R
HANOVICH G
ROSENBERG M
DONOHUE TJ
WEISMAN HF
CALIFF RM
Citation: Fv. Aguirre et al., BLEEDING COMPLICATIONS WITH THE CHIMERIC ANTIBODY TO PLATELET GLYCOPROTEIN IIB IIIA INTEGRIN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION/, Circulation, 91(12), 1995, pp. 2882-2890
Citation: Jc. Blankenship et al., A RANDOMIZED STUDY OF SHEATHS VERSUS GUIDEWIRES FOR ARTERIAL ACCESS DURING ELECTIVE CARDIAC-CATHETERIZATION, The Journal of invasive cardiology, 6(5), 1994, pp. 186-193
Citation: Jc. Blankenship et al., A RANDOMIZED STUDY OF SHEATHS VS GUIDEWIRES FOR ARTERIAL ACCESS DURING ELECTIVE CARDIAC-CATHETERIZATION, Circulation, 88(4), 1993, pp. 251-251